Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brakenhoff

Showing results (341-350 of 460) with videos related to

Pageof 46
Sort By:
The Lancet. Oncology|November 28, 2012
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinomaFrank K J Leusink, Robert J J van Es, Remco de Bree, et al.
The Journal of Infectious Diseases|May 22, 2022
Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis BSylvia M Brakenhoff, Robert J de Knegt, Jeffrey Oliveira, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletionMichaela Wrage, Salla Ruosaari, Paul P Eijk, et al.
Oncotarget|December 13, 2017
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neckD Vicky de Boer, Sanne R Martens-de Kemp, Marijke Buijze, et al.
Molecular Cancer Therapeutics|October 13, 2023
An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with ChemoradiotherapyJantine E Bakema, Marijke Stigter-van Walsum, Jeffrey R Harris, et al.
Biomarker Research|July 16, 2023
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signaturesAnna Corti, Loris De Cecco, Stefano Cavalieri, et al.
Frontiers in Genetics|March 17, 2020
Multi-Omics Analysis Reveals MicroRNAs Associated With Cardiometabolic TraitsMichelle M J Mens, Silvana C E Maas, Jaco Klap, et al.
International Journal of Cancer|March 10, 2000
Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250K Grabmaier, J L Vissers, M C De Weijert, et al.
Molecular Cancer Therapeutics|December 17, 2016
The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional GenomicsSanne R Martens-de Kemp, Arjen Brink, Ida H van der Meulen, et al.
Pageof 46

Showing results (341-350 of 460) with videos related to

Sort By:
Pageof 46
The Lancet. Oncology|November 28, 2012
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinomaFrank K J Leusink, Robert J J van Es, Remco de Bree, et al.
The Journal of Infectious Diseases|May 22, 2022
Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis BSylvia M Brakenhoff, Robert J de Knegt, Jeffrey Oliveira, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletionMichaela Wrage, Salla Ruosaari, Paul P Eijk, et al.
Oncotarget|December 13, 2017
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neckD Vicky de Boer, Sanne R Martens-de Kemp, Marijke Buijze, et al.
Molecular Cancer Therapeutics|October 13, 2023
An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with ChemoradiotherapyJantine E Bakema, Marijke Stigter-van Walsum, Jeffrey R Harris, et al.
Biomarker Research|July 16, 2023
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signaturesAnna Corti, Loris De Cecco, Stefano Cavalieri, et al.
Frontiers in Genetics|March 17, 2020
Multi-Omics Analysis Reveals MicroRNAs Associated With Cardiometabolic TraitsMichelle M J Mens, Silvana C E Maas, Jaco Klap, et al.
International Journal of Cancer|March 10, 2000
Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250K Grabmaier, J L Vissers, M C De Weijert, et al.
Molecular Cancer Therapeutics|December 17, 2016
The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional GenomicsSanne R Martens-de Kemp, Arjen Brink, Ida H van der Meulen, et al.
Pageof 46